Form 8-K - Current report:
SEC Accession No. 0001104659-23-071379
Filing Date
2023-06-15
Accepted
2023-06-15 06:30:20
Documents
12
Period of Report
2023-06-15
Items
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2318768d1_8k.htm   iXBRL 8-K 35967
  Complete submission text file 0001104659-23-071379.txt   216364

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mnk-20230615.xsd EX-101.SCH 3042
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnk-20230615_lab.xml EX-101.LAB 34476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnk-20230615_pre.xml EX-101.PRE 22602
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2318768d1_8k_htm.xml XML 3807
Mailing Address COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN DUBLIN 15 L2 D15
Business Address COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN DUBLIN 15 L2 D15 353 1 6960000
Mallinckrodt plc (Filer) CIK: 0001567892 (see all company filings)

EIN.: 981088325 | Fiscal Year End: 1229
Type: 8-K | Act: 34 | File No.: 001-35803 | Film No.: 231015912
SIC: 2834 Pharmaceutical Preparations